相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peripartum cardiomyopathy: current management and future perspectives
Denise Hilfiker-Kleiner et al.
EUROPEAN HEART JOURNAL (2015)
New insights in prolactin: pathological implications
Valerie Bernard et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Ensembl 2015
Fiona Cunningham et al.
NUCLEIC ACIDS RESEARCH (2015)
Placental antiangiogenic prolactin fragments are increased in human and rat maternal diabetes
P. Perimenis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Arthritis and prolactin: A phylogenetic viewpoint
Norma Adan et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2014)
Vasoinhibins, N-terminal mouse prolactin fragments, participate in mammary gland involution
Michiyo Ishida et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
PAT-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
Khalid Bajou et al.
NATURE MEDICINE (2014)
Pathophysiology and epidemiology of peripartum cardiomyopathy
Denise Hilfiker-Kleiner et al.
NATURE REVIEWS CARDIOLOGY (2014)
Ensembl 2014
Paul Flicek et al.
NUCLEIC ACIDS RESEARCH (2014)
Pro lactin-derived vasoinhibins increase anxiety- and depression-related behaviors
Miriam Zamorano et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
A. Haghikia et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With Preeclampsia
Alfredo Leanos-Miranda et al.
HYPERTENSION (2013)
STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis
Xinhai Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Julie Halkein et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin
Paul J. Declerck et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Prolactin and blood vessels: A comparative endocrinology perspective
Carmen Clapp et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2012)
Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?
Anne Q. Reuwer et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Prolactin and Vasoinhibins: Endogenous Players in Diabetic Retinopathy
Jakob Triebel et al.
IUBMB LIFE (2011)
N-Terminal Prolactin-Derived Fragments, Vasoinhibins, Are Proapoptoptic and Antiproliferative in the Anterior Pituitary
Jimena Ferraris et al.
PLOS ONE (2011)
The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation
Ngoc-Quynh-Nhu Nguyen et al.
PLOS ONE (2011)
Vasoinhibin Gene Transfer by Adenoassociated Virus Type 2 Protects against VEGF- and Diabetes-Induced Retinal Vasopermeability
Mayda Ramirez et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy A Proof-of-Concept Pilot Study
Karen Sliwa et al.
CIRCULATION (2010)
High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
Edith Arnold et al.
DIABETES (2010)
Analysis of Prolactin Gene Expression and Cleaved Prolactin Variants in the Mouse Testis and Spermatozoa
Michiyo Ishida et al.
JOURNAL OF REPRODUCTION AND DEVELOPMENT (2010)
Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth
Virginie Kinet et al.
CANCER LETTERS (2009)
Cathepsin D Is the Primary Protease for the Generation of Adenohypophyseal Vasoinhibins: Cleavage Occurs within the Prolactin Secretory Granules
Martha E. Cruz-Soto et al.
ENDOCRINOLOGY (2009)
Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy
Jakob Triebel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Peptide Hormone Regulation of Angiogenesis
Carmen Clapp et al.
PHYSIOLOGICAL REVIEWS (2009)
Vasoinhibins: novel inhibitors of ocular angiogenesis
Carmen Clapp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
What can we learn from rodents about prolactin in humans?
Nira Ben-Jonathan et al.
ENDOCRINE REVIEWS (2008)
Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes
Alfredo Leanos-Miranda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland
Carmen Clapp et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle
Sabine Erdmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia
Carmen Gonzalez et al.
LABORATORY INVESTIGATION (2007)
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor
Gaoxiang Ge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy
Denise Hilfiker-Kleiner et al.
CELL (2007)
Vasoinhibins:: endogenous regulators of angiogenesis and vascular function
Carmen Clapp et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
The rat prolactin gene family locus: species-specific gene family expansion
S. M. Khorshed Alam et al.
MAMMALIAN GENOME (2006)
Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin
Yazmin Macotela et al.
JOURNAL OF CELL SCIENCE (2006)
Phylogeny and evolution of class-I helical cytokines
MO Huising et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Solution structure of human prolactin
K Teilum et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Prolactins are natural inhibitors of angiogenesis in the retina
J Aranda et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice
H Pan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
16K-Prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation
C Gonzalez et al.
ENDOCRINOLOGY (2004)
Prolactin in eyes of patients with retinopathy of prematurity:: Implications for vascular regression
Z Dueñas et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Limited proteolysis of human growth hormone at low pH: Isolation, characterization, and complementation of the two biologically relevant fragments 1-44 and 45-191
B Spolaore et al.
BIOCHEMISTRY (2004)
Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: Study of their antiangiogenic properties and physiological relevance
D Piwnica et al.
MOLECULAR ENDOCRINOLOGY (2004)
Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary adenoma cell line
G Cosío et al.
LABORATORY INVESTIGATION (2003)
The tertiary structure and backbone dynamics of human prolactin
C Keeler et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system
S Mejía et al.
ENDOCRINE (2003)
The mouse prolactin gene family locus
DO Wiemers et al.
ENDOCRINOLOGY (2003)
Growth hormone and prolactin-molecular and functional evolution
IA Forsyth et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2002)
Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis
AM Corbacho et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Human umbilical vein endothelial cells express multiple prolactin isoforms
AM Corbacho et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin
AM Corbacho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
